Escolar Documentos
Profissional Documentos
Cultura Documentos
Relação temporal - A exposição foi anterior à reação? Qual o tempo entre o início da terapia e a
RAM?
Reexposição - A reação reaparece no caso do medicamento ser readministrado?
Exclusão - Existem outros fatores, além do medicamento suspeito, que possam ter causado o
efeito adverso?
Novidade - A reação foi relatada anteriormente?
Retirada/Suspensão - O paciente melhora após a retirada do medicamento ou redução da dose?
Referências bibliográficas
59. Elzagallaai AA, Rieder MJ. In vitro testing for diagnosis of idiosyncratic adverse drug
reactions: Implications for pathophysiology. British Journal of Clinical Pharmacology. 2014;
80 (4): 890 - 900.
60. Häuser W, Hansen E, Enck P. Nocebo phenomena in medicine: their relevance in everyday
clinical practice. Dtsch Arztebl Int 2012; 109(26): 459–65.
61. Allen EN, Chandler CIR, MandimikaN, Pace C, Mehta U, Barnes KI. Evaluating harm
associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit,
assess and record participant-reported adverse events and related data. Malaria Journal 2013,
12:325
62. Fletcher, RH, Fletcher, SW, Fletcher GS. Epidemiologia Clínica 5ª Ed Porto Alegre: Artmed,
2014 p.208-223 p.280.
63. Oenning D, Oliveira BV, Blatt CR. Conhecimento dos pacientes sobre os medicamentos
prescritos após consulta médica e dispensação. Ciência & Saúde Coletiva 2011; 16(7):3277-
3283.
64. Ferreira MBC, Heineck I, Flores LM, Camargo AL, dal Pizzol TS, Torres ILS ET al. Rational
use of medicines: prescribing indicators at different levels of health care. Brazilian Journal of
Pharmaceutical Sciences 2013; 49: 329-340.
65. Horvat N, Kos M. Contribution of Slovenian community pharmacist counseling to patients’
knowledge about their prescription medicines: a crosssectional study. Croat Med J. 2015;
(56):41-9.
66. Théophile H, André M, Miremont-Salamé G, Arimone Y, Bégaud B. Comparison of three
methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for
the evaluation of routine pharmacovigilance case reports using consensual expert judgement as
reference. Drug Saf 2013; 36(10):1033-44.
67. Théophile H1, Arimone Y, Miremont-Salamé G, Moore N, Fourrier-Réglat A, Haramburu
F, Bégaud B. Comparison of three methods (consensual expert judgement, algorithmic and
probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using
reports made to a French pharmacovigilance centre. Drug Saf. 2010; 33(11):1045-54.
68. Uppsala Monitoring Center. The use of the WHO-UMC system for standardised case causality
assessment. Disponível em: http://who-umc.org/Graphics/24734.pdf Acesso em: 7 nov. 2015.
69. Agbabiaka TB, Savovi´c J, Ernst E. Methods for Causality Assessment of Adverse Drug
Reactions Drug Safety 2008; 31 (1): 21-37.
70. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts E, et al. A method for estimating
the probability of adverse drug reactions. Clin Pharm Ther 1981; 46: 239-245.
71. Wheatley LM, Plaut M, Schwaninger JM, Banerji A, Castells M, Finkelman FD et al. Report
from the National Institute of Allergy and Infectious Diseases workshop on drug allergy J
Allergy Clin Immunol 2015;136 (2) :262-271.
72. Mirakian R, Leech SC, Krishna MT, Richter AG, Huber PA, Farooque S et al. Management of
allergy to penicillins and other beta-lactams. Clin Exp Allergy 2015; 45(2): 300-27.
73. Mangoni AA. Predicting and detecting adverse drug reactions in old age: challenges and
opportunities. Expert Opinion on Drug Metabolism & Toxicology 2012; 8 (5): 527-530.
74. Vinks AA, Emoto C, Fukuda T. Modeling and simulation in pediatric drug therapy: Application
of pharmacometrics to define the right dose for children. Clin Pharmacol Ther 2015; 98(3):298-
308.
75. Nguyen AT, Gentry CA, Furrh RZ. A comparison of adverse drug reactions between high- and
standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
Curr Drug Saf. 2013;8(2):114-9.
76. Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients
with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J
Allergy Clin Immunol 2015;136(2):245-51.
77. McLachlan CY, Yi M, Ling A, Jardine DL. Adverse drug events are a major cause of acute
medical admission. Intern Med J 2014;44(7):633-8.
78. Jolivot PA, Hindlet P, Pichereau C, Fernandez C, Maury E, Guidet B, Hejblum G. A systematic
review of adult admissions to ICUs related to adverse drug events. Crit Care 2014;18(6):643